Veritas In Silico (TSE:130A) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
29 GF Score
Price 円420.00
GF Value 円269.35
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico SpecialCharges?

Special Charges only applies to banks.

TSE:130A
29GF Score
Veritas In Silico Inc TSE:130A
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Veritas In Silico (TSE:130A) Overvalued in 2026?

Based on GuruFocus' analysis, Veritas In Silico stock appears to be overvalued. The current stock price of 円420.00 is trading 55.9% above its estimated GF Value™ of 円269.35. GuruFocus considers Veritas In Silico to be Significantly Overvalued.

Key valuation signals for TSE:130A:

  • SpecialCharges:
  • GF Value™: 円269.35 vs. price of 円420.00 (55.9% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the TSE:130A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
29GF Score

Get the complete analysis for TSE:130A

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円420.00
Price
円269.35
GF Value